Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/836394


Germany Diabetes Care Devices Market Analysis & Forecasts to 2015


Description: Germany Diabetes Care Devices Market Analysis & Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to the Germany diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices market in Germany.

Scope

- The report provides Diabetes care devices market information broken down into detailed categories and segments in Germany.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the diabetes care devices market in Germany.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.


Contents: 1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets Covered in the Report
3.1 Diabetic Care Devices
3.2 Glucose Monitoring Devices
3.2.1 Blood Glucose Meters
3.2.2 Blood Glucose Strips
3.3 Insulin Delivery
3.3.1 Insulin Pens
3.3.2 Insulin Syringes
3.3.3 Insulin Pumps
3.3.4 Traditional Insulin Pump Accessories
4 Healthcare Sector Review
4.1 Healthcare Sector
4.2 Healthcare Expenditure
4.3 Healthcare Infrastructure
4.3.1 Healthcare Personnel Data
4.3.2 Healthcare Facilities Data
4.4 Healthcare Policy
5 Regulation System
5.1 Regulation System
5.2 Medical Equipment Approval Process
5.2.1 Classification of Medical Devices
5.3 Conformity Assessment Process
5.3.1 Class I devices
5.3.2 Class IIa devices
5.3.3 Class IIb devices
5.3.4 Class III devices
5.4 Post Market Surveillance
6 Pricing and Reimbursement
6.1 SHI
6.1.1 Private Health Insurance
6.1.2 Diagnosis Related Groups (DRG)
7 Distribution Structure
8 Diabetes Care Devices In Germany
8.1 A Look In To the Chronic Disease
8.1.1 Type1 and Type2 Diabetes
8.1.2 Diabetes Accentuating Cardiovascular Disease
8.1.3 Diabetes Prevalence
8.2 Diabetes Care Devices, Germany, Overall Revenue ($ m), 2000-2015
8.3 Diabetes Care Devices, Germany, Category Volume (Units), 2000-2015
8.4 Diabetes Care Devices, Germany, Cross Category Analysis, 2000-2015
8.5 German Economic Recession: Impact on the Diabetes Care Devices Market
8.6 Market Dynamics
8.6.1 Market Drivers
8.6.2 Market Restraints
8.7 Diabetes Care Devices, Germany, Company Share (2007-2008)
8.8 Future Outlook
9 Glucose Monitoring In Germany
9.1 Overview
9.2 Glucose Monitoring Overall Revenue (2000-2015)
9.2.1 Blood Glucose Meters Overall Revenue (2000-2015)
9.3 Glucose Monitoring Overall Volume (2000-2015)
9.3.1 Blood Glucose Meters Overall Volume (2000-2015)
9.4 Glucose Monitoring Average Price (2000-2015)
9.5 Glucose Monitoring Market Dynamics
9.5.1 Market Drivers
9.5.2 Market Restraints
9.6 Glucose Monitoring Distribution Share (2007-2008)
9.7 Glucose Monitoring, Germany, Company Share (2007-2008)
10 Insulin Delivery In Germany
10.1 Overview
10.2 Insulin Delivery Overall Revenue (2000-2015)
10.2.1 Insulin Pens Overall Revenue (2000-2015)
10.3 Insulin Delivery Overall Volume (2000-2015)
10.3.1 Insulin Pens Overall Volume (2000-2015)
10.4 Insulin Delivery Average Price (2000-2015)
10.5 Insulin Delivery Market Dynamics
10.5.1 Market Drivers
10.5.2 Market Restraints
10.6 Insulin Delivery Devices Distribution Share (2007-2008)
10.7 Insulin Delivery, Germany, Company Share (2007-2008)
11 Overview of Key Companies in Germany Diabetes Care Devices Market
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 Company Overview
11.1.2 F. Hoffmann-La Roche Ltd Pipeline Products
11.2 Medtronic, Inc.
11.2.1 Company Overview
11.2.2 Medtronic, Inc. Pipeline Products
11.3 LifeScan, Inc.
11.3.1 Company Overview
11.3.2 LifeScan, Inc. Pipeline Products
11.4 Abbott Laboratories
11.4.1 Company Overview
11.4.2 Abbott Laboratories Pipeline Products
11.5 Novo Nordisk A/S
11.5.1 Company Overview
11.5.2 Novo Nordisk A/S Pipeline Products
11.6 Becton, Dickinson and Company
11.6.1 Company Overview
11.7 Eli Lilly and Company
11.7.1 Company Overview
11.7.2 Eli Lilly and Company Pipeline Products
11.8 Bayer HealthCare AG
11.8.1 Company Overview
11.8.2 Bayer HealthCare AG Pipeline Products
11.9 ARKRAY, Inc.
11.9.1 Company Overview
11.9.2 ARKRAY, Inc. Pipeline Products
11.10 Terumo Corporation
11.10.1 Company Overview
11.11 Animas Corporation
11.11.1 Company Overview
11.12 Sanofi-Aventis
11.12.1 Company Overview
11.13 Smiths Medical
11.13.1 Company Overview
11.14 EKF-diagnostic GmbH
11.14.1 Company Overview
12 Appendix
12.1 Research Methodology
12.2 Coverage
12.3 Secondary Research
12.4 Primary Research
12.5 Models
12.6 Forecasts
12.7 Expert Panel Validation
12.8 Currency Conversion
12.9 Contact Us
12.10 Disclaimer

1.1 List of Tables
Table 1: Healthcare Expenditure in Germany, (€m), 2000 - 2006
Table 2: Healthcare Personnel by Region in Germany, 2007
Table 3: Doctors by Specialty in Germany, 2000-2004
Table 4: Hospitals by Region in Germany, 2004
Table 5: Hospitals and Beds by Region in Germany, 2007
Table 6: Rehabilitation Centers by Region in Germany, 2004
Table 7: Rehabilitation Center Beds by Region in Germany, 2004
Table 8: Discharges by Diagnosis in Germany, 2004
Table 9: Diabetes Prevalence Rates, 2007
Table 10: Diabetes Care Devices, Germany, Overall Revenue ($ m), Historic, 2000-2008
Table 11: Diabetes Care Devices, Germany, Overall Revenue ($ m), Forecast, 2008-2015
Table 12: Diabetes Care Devices, Germany, Category Volume (Units), Historic, 2000-2008
Table 13: Diabetes Care Devices, Germany, Category Volume (Units), Forecast, 2008-2015
Table 14: Diabetes Care Devices, Germany, Cross-Category Analysis, 2000-2015
Table 15: Diabetes Care Devices, Germany, Company Share by Revenue ($ m), 2007-2008
Table 16: Glucose Monitoring, Germany, Revenue ($ m) by Segment, Historic, 2000-2008
Table 17: Glucose Monitoring, Germany, Revenue ($ m) by Segment, Forecast, 2008-2015
Table 18: Blood Glucose Meters, Germany, Revenue ($ m) by Sub-Segment, Historic, 2000-2008
Table 19: Blood Glucose Meters, Germany, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015
Table 20: Glucose Monitoring, Germany, Volume (Units) by Segment, Historic, 2000-2008
Table 21: Glucose Monitoring, Germany, Volume (Units) by Segment, Forecast, 2008-2015
Table 22: Blood Glucose Meters, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 23: Blood Glucose Meters, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 24: Glucose Monitoring, Germany, Average Price ($), Historic, 2000-2008
Table 25: Glucose Monitoring, Germany, Average Price ($), Forecast, 2008-2015
Table 26: Glucose Monitoring, Germany, Distribution Share by Revenue ($mn), 2007-2008
Table 27: Glucose Monitoring, Germany, Company Share by Revenue ($ m), 2007-2008
Table 28: Insulin Delivery, Germany, Revenue ($ m) by Segment, Historic, 2000-2008
Table 29: Insulin Delivery, Germany, Revenue ($ m) by Segment, Forecast, 2008-2015
Table 30: Insulin Pens, Germany, Revenue ($ m) by Sub-Segment, Historic, 2000-2008
Table 31: Insulin Pens, Germany, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015
Table 32: Insulin Delivery, Germany, Volume (Units) by Segment, Historic, 2000-2008
Table 33: Insulin Delivery, Germany, Volume (Units) by Segment, Forecast, 2008-2015
Table 34: Insulin Pens, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 35: Insulin Pens, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 36: Insulin Delivery, Germany, Average Price ($), Historic, 2000-2008
Table 37: Insulin Delivery, Germany, Average Price ($), Forecast, 2008-2015
Table 38: Insulin Delivery, Germany, Distribution Share by Revenue ($mn), 2007-2008
Table 39: Insulin Delivery, Germany, Company Share by Revenue ($ mn), 2007-2008
Table 40: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type
Table 41: F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage
Table 42: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy Area
Table 43: Medtronic, Inc. Pipeline Products by Equipment Type
Table 44: Medtronic, Inc. Pipeline Products By Development Stage
Table 45: Medtronic, Inc. Pipeline Products By Therapy Area
Table 46: Medtronic, Inc. Pipeline Products By Clinical Trials
Table 47: Medtronic, Inc. Pipeline Products By News Summary
Table 48: LifeScan, Inc. Pipeline Products by Equipment Type
Table 49: LifeScan, Inc. Pipeline Products by Development Stage
Table 50: LifeScan, Inc. Pipeline Products by Therapy Area
Table 51: LifeScan, Inc. Pipeline Products by Clinical Trials
Table 52: LifeScan, Inc. Pipeline Products by News Summary
Table 53: Abbott Laboratories Pipeline Products by Equipment Type
Table 54: Abbott Laboratories Pipeline Products by Development Stage
Table 55: Abbott Laboratories Pipeline Products by Therapy Area
Table 56: Abbott Laboratories Pipeline Products by Clinical Trials
Table 57: Abbott Laboratories Pipeline Products by News Summary
Table 58: Novo Nordisk A/S Pipeline Products by Equipment Type
Table 59: Novo Nordisk A/S Pipeline Products By Development Stage
Table 60: Novo Nordisk A/S Pipeline Products By Therapy Area
Table 61: Novo Nordisk A/S Pipeline Products By Clinical Trials
Table 62: Eli Lilly and Company Pipeline Products by Equipment Type
Table 63: Eli Lilly and Company Pipeline Products by Development Stage
Table 64: Eli Lilly and Company Pipeline Products by Therapy Area
Table 65: Eli Lilly and Company Pipeline Products by Clinical Trials
Table 66: Eli Lilly and Company Pipeline Products by News Summary
Table 67: Bayer HealthCare AG Pipeline Products by Equipment Type
Table 68: Bayer HealthCare AG Pipeline Products by Development Stage
Table 69: Bayer HealthCare AG Pipeline Products by Therapy Area
Table 70: Bayer HealthCare AG Pipeline Products by News Summary
Table 71: ARKRAY, Inc. Pipeline Products by Equipment Type
Table 72: ARKRAY, Inc. Pipeline Products by Development Stage
Table 73: ARKRAY, Inc. Pipeline Products by Clinical Trials
Table 74: ARKRAY, Inc. Pipeline Products by News Summary
Table 75: USD to Local Currency, Average Exchange Rate 2008

1.2 List of Figures
Figure 1: Healthcare Expenditure Sources in Germany, 2006
Figure 2: Healthcare Financing Framework in Germany, 2007
Figure 3: Flowchart for Classification of Non-invasive Devices in Germany, 2007
Figure 4: Flowchart for Classification of Invasive Devices in Germany, 2007
Figure 5: Flowchart for Classification of Invasive Devices in Germany, 2007
Figure 6: Classification of Invasive Devices in Germany, 2007
Figure 7: Classification of Invasive Devices in Germany, 2007
Figure 8: Flowchart for Classification of Active Devices in Germany, 2007
Figure 9: Flowchart for Classification of Active Devices in Germany, 2007
Figure 10: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Germany, 2007
Figure 11: Conformity Assessment of Class-I Medical Devices in Germany, 2007
Figure 12: Conformity Assessment of Class-IIa Medical Devices in Germany, 2007
Figure 13: Conformity Assessment of Class-IIb Medical Devices in Germany, 2007
Figure 14: Conformity Assessment of Class-III Medical Devices in Germany, 2007
Figure 15: Diabetes Care Devices, Germany, Overall Revenue ($ m), Historic, 2000-2008
Figure 16: Diabetes Care Devices, Germany, Overall Revenue ($ m), Forecast, 2008-2015
Figure 17: Diabetes Care Devices, Germany, Category Volume (Units), Historic, 2000-2008
Figure 18: Diabetes Care Devices, Germany, Category Volume (Units), Forecast, 2008-2015
Figure 19: Diabetes Care Devices, Germany, Cross-Category Analysis, 2000-2015
Figure 20: Diabetes Care Devices, Germany, Company Share (%), 2008
Figure 21: Glucose Monitoring, Germany, Revenue ($ m) by Segment, Historic, 2000-2008
Figure 22: Glucose Monitoring, Germany, Revenue ($ m) by Segment, Forecast, 2008-2015
Figure 23: Blood Glucose Meters, Germany, Revenue ($ m) by Sub-Segment, Historic, 2000-2008
Figure 24: Blood Glucose Meters, Germany, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015
Figure 25: Glucose Monitoring, Germany, Volume (Units) by Segment, Historic, 2000-2008
Figure 26: Glucose Monitoring, Germany, Volume (Units) by Segment, Forecast, 2008-2015
Figure 27: Glucose Monitoring, Germany, Company Share (%), 2008
Figure 28: Insulin Delivery, Germany, Revenue ($ m) by Segment, Historic, 2000-2008
Figure 29: Insulin Delivery, Germany, Revenue ($ m) by Segment, Forecast, 2008-2015
Figure 30: Insulin Pens, Germany, Revenue ($ m) by Sub-Segment, Historic, 2000-2008
Figure 31: Insulin Pens, Germany, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015
Figure 32: Insulin Pens, Germany, Volume (Units) by Sub-Segment, Historic, 2000-2008
Figure 33: Insulin Pens, Germany, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Figure 34: Insulin Delivery, Germany, Company Share (%), 2008
Figure 35: Methodology


Companies Mentioned F. Hoffmann-La Roche Ltd. Medtronic, Inc. LifeScan, Inc. Abbott Laboratories Novo Nordisk A/S Becton, Dickinson and Company Eli Lilly and Company Bayer HealthCare AG ARKRAY, Inc. Terumo Corporation Animas Corporation Sanofi-Aventis Smiths Medical EKF-diagnostic GmbH


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/836394

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 15/02/2012 18:20:39
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Germany Diabetes Care Devices Market Analysis & Forecasts to 2015
Web Address:
http://www.researchandmarkets.com/reports/836394
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €2,641.00
Electronic (PDF) - Site License €5,281.00
Electronic (PDF) - Enterprisewide €7,922.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 15/02/2012 18:20:39

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)